kollectore

[kollectore @kollectore]

Yes ser, the source can’t be studied by its reflection; just like characters in a movie couldn’t possibly comprehend their origin within a single ray of light.
I think Gödel’s incompleteness theorem captures this paradox well, in that consciousness lies within a set of problems that can’t be solved from inside the same system. Anything and everything can only ever be observed from the reference frame of the observer (consciousness itself).

[kollectore @kollectore]

@KobeissiLetter Wasn’t that the final step of the master plan?

[kollectore @kollectore]

@Yuchenj_UW Variance

[aaalex.hl @aaalexhl]

Hyperliquid was born from the mistakes of FTX and Binance

The same Binance that liquidates the market whenever they feel like, sells off every major on a daily basis, and has been accused of back room deals for years

This is the first DEX in Crypto that actually scales and rivals tier 1 centralized exchanges

It's proven time and time again it's a viable replacement, and this industry has begged for something like this for a decade

They don't sell assets on the side, every aspect of the protocol is transparent, and Jeff doesn't tweet bullshit

If Hyperliquid fails (it won't), you should accept what Crypto has become and decide whether or not that's the future you want to participate in

[kollectore @kollectore]

I’m fairly sure there’s enough latent demand for your analyses on a lot of individual issues eg. $YZY and it’s just more of a distribution issue. Why not create or use existing infra to fundraise for individual issues such as these and only start research if the targets are met? Reward contributors with early access to the report perhaps to incentivise.

[kollectore @kollectore]

@dylanottt @cluely Interested!

[kollectore @kollectore]

@mynamebedan I’ve been dreaming up a platform just like this, would love to test and provide feedback.

[kollectore @kollectore]

@JosephKChoi Coool, would love to join

[kollectore @kollectore]

@architjn Research

[kollectore @kollectore]

@jspujji Growth assistant

[kollectore @kollectore]

The fundamental metrics are a direct consequence of a good product. Ethereum with pecta upgrade will enable equally scalable and performant alternatives to hyper liquid, with the opportunity to vampire attack HL through gamified incentives (blur vs. OpenSea sort of situation). HL has no particular moat that’s necessarily ‘sticky’ enough to persuade people from not shifting.

[kollectore @kollectore]

@DarkCryptoLord @cryptocom This has always been the case with @cryptocom, thanks for the heads up ser.

[kollectore @kollectore]

@RiddlerDeFi It is possible to sell, only on cexes though. A lot of pi miners locked up their tokens for up to 3 years (or less, you could choose how long).
Price is maintaining because people have forgotten the impact of equitable distribution on price action. Hence the confusion.

[Sam Altman @sama]

!!

[kollectore @kollectore]

@GoodIDeaDudes Sorry, just came across your profile, but is there something specific you’re attempting to treat with it? Curious.

[kollectore @kollectore]

@GoodIDeaDudes @MakisMD @elonmusk @MakisMD

https://t.co/otxUeSLc4K

[kollectore @kollectore]

To give credit where credit is due, I’ve been looking into ivermectin/fenben related treatments for cancer on behalf of a friend recently, and Grok has been the only LLM that won’t outright refuse to provide any information on it (as opposed to incumbents that very clearly have hardcoded responses for similar queries). On the contrary it has been super helpful and ironically led me to your profile @MakisMD.
So the issue may be more nuanced than it appears at first glance. As some have mentioned the issue may just be attributed to a lack/suppression/deliberate deletion of information as a whole across the interweb through the lobbying efforts of pharmaceuticals as opposed to any inherent issue with Grok itself. So may be a more collaborative approach, as opposed to finger pointing, may be more conducive to this conversation @MakisMD @elonmusk.

[kollectore @kollectore]

To give credit where credit is due, I’ve been looking into ivermectin/fenben related treatments for cancer on behalf of a friend recently, and Grok has been the only LLM that won’t outright refuse to provide any information on it (as opposed to incumbents that very clearly have hardcoded responses for similar queries). On the contrary it has been super helpful and ironically led me to your profile @MakisMD.
So the issue may be more nuanced than it appears at first glance. As some have mentioned the issue may just be attributed to a lack/suppression/deliberate deletion of information as a whole across the interweb through the lobbying efforts of pharmaceuticals as opposed to any inherent issue with Grok itself. So may be a more collaborative approach, as opposed to finger pointing, may be more conducive to this conversation @MakisMD @elonmusk.

[kollectore @kollectore]

@Dynamo_Patrick Lambo, many lambo

[kollectore @kollectore]

@boxmining @milesdeutscher @buda_kyiv Making this shit up to pocket user funds is much easier